Understanding and Managing Pain for Thalidomide Survivors

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

February 2, 2025

Study Completion Date

February 2, 2025

Conditions
Pain, ChronicPain
Interventions
OTHER

Usual Care

Usual Care includes among others, over-the-counter or prescribed painkillers, treatment modalities such as physiotherapy and/or psychotherapy, privately accessed or via the National Health Service, exercise, etc.

Trial Locations (1)

NG5 1PB

Clinical Sciences Building - City Hospital Campus, Nottingham

All Listed Sponsors
collaborator

The Thalidomide Trust

UNKNOWN

lead

University of Nottingham

OTHER

NCT06398132 - Understanding and Managing Pain for Thalidomide Survivors | Biotech Hunter | Biotech Hunter